Tag: Dentistry Impact Award

Johanna Gaß | Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Johanna Gaß | Dentistry | Best Researcher Award

Private Practice, Germany

Dr. Johanna Alexandra Gaß, M.Sc., is an emerging expert in periodontology, implant therapy, and aesthetic restorative dentistry, recognized for her evidence-based approach and scientific precision. She completed her Doctorate in Medicine (magna cum laude) at the University Hospital Heidelberg, where her research focused on the prognostic relevance of genetic signatures in head and neck squamous cell carcinoma—an interdisciplinary study bridging molecular oncology and clinical outcomes. Her academic foundation is strengthened by a Master of Science in “Parodontologie und Implantattherapie” from the Dresden International University (DIU), awarded with highest distinction. Professionally, Dr. Gaß has gained extensive clinical and research experience through her work in leading dental and periodontal practices in Frankfurt and Berlin, combining clinical excellence with innovative methodologies in advanced implantology and minimally invasive periodontal therapy. Dr. Gaß has contributed several peer-reviewed publications in high-impact journals such as International Journal of Cancer and Clinical Advances in Periodontics, alongside conference presentations at prestigious national meetings including the DGParo Annual Congress. Her research on ceramic veneer restorations in periodontally compromised patients and cathepsin-related mechanisms in periodontal disease demonstrates her ability to integrate translational research with clinical applicability. With growing scholarly recognition, her academic output includes multiple collaborative works with leading clinicians and researchers across Germany, emphasizing the importance of interdisciplinary integration between basic science and clinical dentistry. Her research and clinical practice focus on digitalization in dental workflows, regenerative periodontal therapy, and personalized treatment planning—fields central to the modernization of oral healthcare. As a B. Braun Foundation Scholar and Young Speaker for the ARPA Foundation, she has demonstrated leadership and commitment to advancing professional education. Dr. Gaß’s contributions extend beyond the clinic, influencing dental science through research, teaching, and innovation, aimed at improving global oral health outcomes and promoting sustainable, patient-centered dentistry.

Profile: ORCID

Featured Publications

  1. Bäumer, A. M., Riemer, C. T., Büsch, C., Körner, G. A., & Gaß, J. A. (2025). Patient satisfaction among periodontally stable patients with veneer restorations—A retrospective study. Clinical Advances in Periodontics.

  2. Gaß, J. A., Büsch, C., Körner, G. A., & Bäumer, A. M. (2023). Ceramic anterior veneer restorations in periodontally compromised patients: A retrospective study. Clinical Advances in Periodontics.

  3. Plath, M., Gaß, J., Hlevnjak, M., Li, Q., Feng, B., Pastor Hostench, X., Bieg, M., Schroeder, L., Holzinger, D., Zapatka, M., et al. (2021). Unraveling most abundant mutational signatures in head and neck cancer. International Journal of Cancer, 148(1).

Dr. Johanna Gaß’s work bridges scientific research and clinical innovation in periodontology and implant therapy, advancing evidence-based, minimally invasive treatments that enhance long-term oral health outcomes. Her integration of digital dentistry, regenerative approaches, and translational research fosters global progress toward personalized, sustainable, and patient-centered dental care.

Travis Nelson | Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Travis Nelson | Dentistry | Best Researcher Award

University of Washington, United States

Dr. Travis M. Nelson, DDS, MSD, MPH, is a distinguished pediatric dentist and academic leader with extensive expertise in clinical practice, research, and education. He earned his BA from Walla Walla College in 2003, DDS from Loma Linda University in 2007, and MSD/MPH from the University of Washington in 2010. Currently a tenured Associate Professor at the University of Washington, he has held multiple academic appointments, including Clinical and Tenure-Track Associate Professor, Chair of the Department of Pediatric Dentistry, Interim Predoctoral Director, Graduate Program Director, and Acting Chair, demonstrating strong leadership and commitment to advancing pediatric oral health education. Dr. Nelson’s professional experience is complemented by his service on the medical staff at Seattle Children’s Hospital and active involvement in professional organizations, including the American Academy of Pediatric Dentistry, Western Society of Pediatric Dentistry, and American Dental Education Association. His research interests focus on pediatric oral health, early childhood caries prevention, dental sedation and anesthesia, and improving access to dental care for children with special needs. He has authored 37 publications with 521 citations and an h-index of 12, reflecting significant contributions to the scientific literature. Dr. Nelson is highly skilled in clinical pediatric dentistry, procedural sedation, dental public health research, and interdisciplinary program development. His numerous awards and honors include the Law Lewis Endowed Chair, multiple UW Pediatric Dentistry Resident Teaching Awards, Jerome B. Miller “For the Kids” Award, recognition as a Top Dentist by Seattle Metropolitan Magazine, and multiple national and international research fellowships and scholarships. He has also mentored numerous graduate students and residents, guiding impactful research projects on pediatric sedation, dental behavior, and preventive care. Overall, Dr. Nelson’s career exemplifies a seamless integration of clinical excellence, innovative research, and educational leadership, positioning him as a leading figure in pediatric dentistry whose work continues to advance knowledge, improve clinical outcomes, and foster the development of future dental professionals.

Profile: Scopus

Featured Publications

  1. Nelson, T. M., Berg, J. H., Bell, J. F., Leggott, P. J., & Seminario, A. L. (2011). Assessing the effectiveness of text messages as appointment reminders in a pediatric dental setting. Journal of the American Dental Association, 142(4), 397–405.

  2. Nelson, T. M. (2011). The key to caries prevention. Dimensions of Dental Hygiene, 9(7), 48–50, 52–53.

  3. Nelson, T. M. (2012). The consequences of convenience. Dimensions of Dental Hygiene, 10(2), 30–32, 34.

  4. Nelson, T. M. (2013). An improved interim therapeutic restoration (ITR) technique for management of anterior early childhood caries. Pediatric Dentistry, 35(4), 124–128.

  5. Nelson, T., & Nelson, G. (2013). The role of sedation in contemporary pediatric dentistry. Dental Clinics of North America, 57(1), 145–161.

Dr. Travis M. Nelson’s work advances pediatric oral health by improving early childhood caries prevention, optimizing sedation and anesthesia protocols, and expanding access to dental care for children with special needs. His research and educational initiatives bridge clinical practice and public health, fostering healthier communities and shaping the next generation of dental professionals globally.

HYO-SANG PARK | Dentistry | Excellence in Research Award

Published on by WSA Awards

Prof. HYO-SANG PARK | Dentistry | Excellence in Research Award

Department of Orthodontics, Kyungpook National Univsersity, South Korea

Prof. Hyo-Sang Park, DDS, MSD, Ph.D., is a distinguished scholar, clinician, and global leader in orthodontics, widely recognized for pioneering orthodontic microimplants that have revolutionized treatment protocols worldwide. He completed his Doctor of Dental Surgery (DDS) at Kyungpook National University in Daegu, Korea, followed by specialist orthodontic training and authorization at Kyungpook National University Hospital. He earned a Master of Science in Orthodontics and later obtained his Ph.D. in Oral Biology and Orthodontics from Kyungpook National University, reflecting a solid academic foundation. Professionally, he has served as a full-time instructor, assistant professor, and associate professor at Keimyung University Medical College before becoming Professor and Chair of the Department of Orthodontics at Kyungpook National University, while also enriching his international exposure as a Visiting Associate Professor at the University of Oklahoma, USA. His research interests include the development of orthodontic microimplants, microimplant-assisted orthodontic treatment, clear aligner-microimplant combined treatment, and orthognathic surgery. With expertise spanning biomechanics, surgical orthodontics, device design, and clinical applications, his research skills have resulted in over 114 indexed publications, 4,303 citations, and an h-index of 33, alongside multiple patents for orthodontic anchorage systems and innovative devices. His books and monographs, translated into Korean, English, Japanese, Chinese, Spanish, and Portuguese, further highlight his international influence, and his more than 200 lectures, 300 training courses, and global presentations underscore his role as a thought leader and educator. Prof. Park has received widespread recognition for his contributions, including leadership in academic societies, authorship of standard orthodontic textbooks, and patents that bridge clinical innovation with patient care. In conclusion, Prof. Hyo-Sang Park’s career reflects an exceptional blend of academic excellence, pioneering research, international collaboration, and mentorship, making him highly deserving of global recognition for his transformative contributions to orthodontics and his ongoing potential to advance the field through innovation, leadership, and education.

Profile: Scopus | ORCID | Google Scholar

Featured Publication

Park, H. S., Jeong, S. H., & Kwon, O. W. (2006). Factors affecting the clinical success of screw implants used as orthodontic anchorage. American Journal of Orthodontics and Dentofacial Orthopedics, 130(1), 18–25.  — Cited 984

Park, H. S. (2001). MIA (Micro-Implant Anchorage) for Class I bialveolar protrusion. Journal of Clinical Orthodontics, 35(7), 417–422. — Cited 803

Kyung, H. M., Park, H. S., Bae, S. M., & Jae-Hyun, S. (2003). Overview: Development of orthodontic micro-implants for intraoral anchorage. Journal of Clinical Orthodontics, 37(6), 321–328. — Cited 718

Bae, S., Park, H. S., Kyung, H. M., Kwon, O. W., & Sung, J. H. (2002). Clinical application of micro-implant anchorage. Journal of Clinical Orthodontics, 36(5), 298–302. — Cited 583

Lee, M. H., Kwon, T. G., Park, H. S., Wozney, J. M., & Ryoo, H. M. (2003). BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochemical and Biophysical Research Communications, 309(3), 689–694. Cited 561

Maryam Ghasempour | Dentistry | Women Researcher Award

Published on by WSA Awards

Prof. Dr. Maryam Ghasempour | Dentistry | Women Researcher Award

Babol University of Medical Sciences, Iran

Professor Maryam Ghasempour is a distinguished academic and researcher in pediatric dentistry, with over three decades of experience in clinical practice, teaching, and research. She currently serves as the Head of Postgraduate Studies in the Pediatric Dentistry Department at Babol University of Medical Sciences, where she is also a member of the Research Council and Oral Health Research Center. She has played a key role in advancing pediatric dental research, particularly in the areas of microbiology, dental anomalies, and preventive dentistry. Having published extensively in national and international journals, Professor Ghasempour has contributed significantly to the understanding of oral health in children. Her leadership extends to organizing academic events, including serving as the President of the 21st Congress of the Iranian Association of Pediatric Dentistry in 2024. She has also mentored numerous postgraduate students, fostering the next generation of dental researchers. Her commitment to evidence-based pediatric dentistry and public health initiatives highlights her influence in the field.

Professional Profile

Education

Professor Maryam Ghasempour’s academic journey began with a Doctorate of Dentistry from Shahid Beheshti Dental School in Tehran, Iran, in 1990. She then specialized in pediatric dentistry, earning a Pedodontics degree from Mashhad Dental School in 1995. Her dedication to furthering her expertise led her to Cardiff University in the United Kingdom, where she completed a fellowship in pediatric dentistry in 2002. This international training enriched her knowledge in advanced techniques and methodologies within pediatric dentistry. Over the years, she has continued her academic progression, achieving the rank of Associate Professor in 2016 and later being promoted to Full Professor at Babol University of Medical Sciences in 2024. Her strong academic background, coupled with extensive research and clinical experience, has established her as a leading expert in pediatric dentistry, with a focus on innovative treatment modalities, oral microbiology, and preventive dental care.

Professional Experience

Professor Ghasempour’s career spans several prestigious roles within the field of pediatric dentistry. She began as an Assistant Professor at Babol University of Medical Sciences in 1995 and has since progressed to Full Professor in 2024. Throughout her career, she has held key administrative and leadership positions, including serving as the Head of Postgraduate Studies in the Pediatric Dentistry Department and as a member of the Research Council at Babol Dental School. She has played an active role in curriculum development, postgraduate mentorship, and interdisciplinary research collaborations. Her influence extends beyond academia, as she has been involved in organizing national and international conferences, including serving as the President of the 21st Congress of the Iranian Association of Pediatric Dentistry in 2024. Her professional contributions have significantly advanced pediatric dental research and education in Iran and beyond.

Research Interests

Professor Ghasempour’s research focuses on various aspects of pediatric dentistry, including dental microbiology, preventive dentistry, oral health epidemiology, and dental anomalies. She has conducted extensive studies on the role of oral microbiota in early childhood caries, biofilm formation, and the effects of probiotics and natural extracts on dental pathogens. Additionally, she has explored dental developmental anomalies and their clinical implications, as well as the relationship between systemic conditions and oral health. Her research also extends to evaluating new treatment materials, such as fluoride-releasing compounds and antimicrobial agents, for their effectiveness in pediatric dental care. With a strong interest in public health dentistry, she has worked on projects assessing oral health awareness and preventive strategies among children and their families. Her interdisciplinary approach to research has led to numerous high-impact publications in international journals.

Research Skills

Professor Ghasempour possesses a diverse range of research skills that have contributed to her extensive body of work. She is proficient in clinical research methodologies, statistical analysis, and laboratory-based microbiological studies. Her expertise includes in vitro and in vivo experimental designs, molecular microbiology techniques, and biomaterial testing for pediatric dentistry applications. Additionally, she has experience in epidemiological research, conducting large-scale surveys on oral health and dental care practices among pediatric populations. Her ability to integrate clinical practice with scientific inquiry has allowed her to develop innovative approaches for diagnosing and managing pediatric dental conditions. Furthermore, she has strong mentorship skills, guiding postgraduate students in their research endeavors. Her work often involves interdisciplinary collaborations, bridging gaps between dentistry, microbiology, and public health to enhance the understanding and treatment of childhood dental diseases.

Awards and Honors

Throughout her career, Professor Ghasempour has received several awards and recognitions for her contributions to pediatric dentistry and research. Her work has been widely acknowledged in national and international forums, and she has been a recipient of multiple research grants supporting her innovative studies in oral health. As a prominent researcher, she has also been invited to present at numerous academic conferences and serve as a keynote speaker. Her leadership in the field has led to her appointment as the President of the 21st Congress of the Iranian Association of Pediatric Dentistry in 2024. Additionally, her role in advancing dental education and research has been recognized by Babol University of Medical Sciences, where she has played a crucial role in shaping postgraduate programs. These accolades reflect her dedication to improving pediatric dental care through research, education, and public health initiatives.

Conclusion

Professor Maryam Ghasempour is a leading figure in pediatric dentistry, with a distinguished career spanning research, education, and clinical practice. Her extensive publication record, leadership roles, and contributions to dental education have made a lasting impact on the field. She has played a crucial role in advancing pediatric dental research, particularly in microbiology, preventive dentistry, and dental anomalies. Her dedication to mentorship and academic leadership has shaped the next generation of dental professionals. As an advocate for evidence-based dentistry, she continues to contribute to the development of innovative treatment approaches and public health strategies aimed at improving oral health outcomes in children. Through her expertise, research, and leadership, she has established herself as a key figure in pediatric dentistry, making significant strides in both national and international dental communities.

Publications Top Notes

  1. Evaluation of salivary thiobarbituric acid reactive substances, total protein, and pH in children with various degrees of early childhood caries: a case-control study

    • Authors: Aliakbarpour F, Mahjoub S, Masrour-Roudsari J, Seyedmajidi S, Ghasempour M

    • Year: 2021

  2. The association between the salivary cortisol level of mothers, children’s temperament, and early childhood caries

    • Authors: Abedizadeh H, Faramarzi M, Khafri S, Qujeq Q, Ahangary M, Ghasempour M

    • Year: 2021

  3. Anti-Streptococcus mutans property of a chitosan-containing resin sealant

    • Authors: Rajabnia R, Ghasempour M, Gharekhani S, Gholamhoseinnia S, Soroorhomayoon S

    • Year: 2016

  4. Comparative in vitro study of the effectiveness of Green tea extract and common storage media on periodontal ligament fibroblast viability

    • Authors: Adeli F, Zabihi E, Abedian Z, Gharekhani S, Pouramir M, Khafri S, Ghasempour M

    • Year: 2016

  5. Impact of oral and dental health on quality of life in Iranian preschool children and their families

    • Authors: Nemati S, Ghasempour M, Khafri S

    • Year: 2016

  6. Effect of aqueous and ethanolic extracts of Lippia citriodora on Candida albicans

    • Authors: Ghasempour M, Omran SM, Moghadamnia AA, Shafiee F

    • Year: 2016

  7. Relationship between Learning Style and Academic Status of Babol Dental Students

    • Authors: Nasiri Z, Gharekhani S, Ghasempour M

    • Year: 2016

  8. Effect of milk and yogurt on Streptococcus sobrinus counts and caries score in rats

    • Authors: Ghasempour M, Rajabnia R, Ashrafpour M, Ehsani A, Moghadamnia AA, Gharekhani S, Shahandashti EF, Bagheri M

    • Year: 2015

  9. In vitro viability of human periodontal ligament cells in green tea extract

    • Authors: Ghasempour M, Moghadamnia AA, Abedian Z, Amir MP, Feizi F, Gharekhani S

    • Year: 2015

Charles Cobb | Dentistry | Excellence in Research

Published on by WSA Awards

Dr. Charles Cobb | Dentistry | Excellence in Research

Professor Emeritus at University of Missouri-Kansas City, United States

Dr. Charles M. Cobb, D.D.S., M.S., Ph.D., is a Professor Emeritus in the Department of Periodontics at the University of Missouri-Kansas City School of Dentistry. With over five decades of academic, clinical, and research experience, Dr. Cobb has established himself as a leading expert in periodontics and related fields. His interdisciplinary training, which spans dentistry, microbiology, anatomy, and cell biology, underscores his broad expertise. A dedicated educator and researcher, Dr. Cobb has contributed significantly to advancing periodontal sciences through teaching, mentorship, and scholarly work. His career includes leadership roles in developing advanced academic programs and shaping the next generation of periodontists. He has also practiced clinically, providing comprehensive periodontal care alongside his academic endeavors.

Professional Profile

Education

Dr. Cobb’s academic credentials reflect a commitment to excellence and interdisciplinary study. He earned his Doctor of Dental Surgery (D.D.S.) from the University of Missouri-Kansas City in 1964, followed by a Certificate in Periodontics and a Master of Science in Microbiology in 1966. He further pursued a Ph.D. in Anatomy, with a specialization in Microanatomy and Cell Biology, from Georgetown University in 1971. In addition to his formal degrees, Dr. Cobb completed military training programs, including courses at the U.S. Navy Officer Candidate School and the National Defense University, further enhancing his leadership and organizational skills.

Professional Experience

Dr. Cobb’s professional career encompasses a diverse range of roles in academia, clinical practice, and administration. He began his career in the U.S. Navy Dental Corps, where he served as Director of Courses in Mass Casualty Triage and Combat First Aid. He has held academic positions at institutions such as Louisiana State University, the University of Alabama in Birmingham, and the University of Missouri-Kansas City (UMKC). At UMKC, Dr. Cobb advanced through the ranks to become Professor of Periodontics and Oral Biology and later Professor Emeritus. He has also maintained private periodontal practices, balancing clinical excellence with academic commitments. His leadership roles include serving as Interim Director of Graduate Periodontics at UMKC.

Research Interests

Dr. Cobb’s research interests lie at the intersection of periodontics, implantology, and oral biology. He has explored the ultrastructural biology of the periodontium, microbiology of periodontal diseases, and bone physiology, particularly in the context of dental implant integration and peri-implant diseases. His work includes studies on bone formation, osseointegration, and the cellular and microbial dynamics of periodontal tissues. Dr. Cobb’s interdisciplinary approach integrates anatomy, microbiology, and clinical periodontics, making his research highly relevant to advancing both fundamental knowledge and practical applications in periodontal care.

Research Skills

Dr. Cobb possesses a robust set of research skills that have driven his academic and clinical contributions. He is proficient in histological and histochemical techniques, with expertise in microanatomy and cell biology. His work has involved advanced microscopy, microbial analysis, and experimental design for studying periodontal and implant-related conditions. Dr. Cobb has also demonstrated leadership in coordinating research projects, mentoring graduate students, and integrating research findings into clinical practice. His ability to translate complex scientific concepts into practical applications underscores his effectiveness as a researcher and educator.

Awards and Honors

Dr. Cobb has been recognized for his significant contributions to periodontics and dental education. He achieved Diplomate status with the American Board of Periodontology, maintaining recertifications throughout his career until his retirement. His tenure as Professor Emeritus at UMKC reflects his long-standing impact on the academic community. Additionally, his service in the U.S. Navy and his academic leadership roles further highlight his commitment to excellence and professional integrity. Dr. Cobb’s awards and honors underscore his dedication to advancing periodontal science and education.

Conclusion

Dr. Charles M. Cobb’s distinguished career exemplifies a lifetime commitment to excellence in periodontics, education, and research. His interdisciplinary expertise, spanning microbiology, anatomy, and clinical periodontics, has contributed to advancing knowledge and improving clinical outcomes. As an educator, he has shaped the careers of countless dental professionals through innovative teaching and mentorship. His research has addressed critical challenges in periodontal and implant sciences

Publication Top Notes

  1. Perigraftitis and implant therapy: A case report
    • Authors: Do, J.H., Cobb, C.M.
    • Year: 2024
  2. The need for updated treatment- and outcomes-based guidelines for periodontal therapy
    • Authors: Harrel, S.K., Cobb, C.M.
    • Year: 2024
  3. Calculus: A risk factor for failed periodontal therapy
    • Authors: Harrel, S.K., Cobb, C.M.
    • Year: 2024
    • Citations: 1
  4. Development of Root Caries Associated with the Use of Sugar-Free Nicotine Lozenges: A Long-Term Case Report
    • Authors: Ehrhardt, C., Mäkinen, K.K., Cobb, C.M.
    • Year: 2024
  5. Laser and scanning electron microscopy evaluation of residual microislands of calculus
    • Authors: Harrel, S.K., Cobb, C.M., Nunn, M.E., Zhao, D.
    • Year: 2024
  6. A randomized double-blind clinical trial evaluating comparative plaque and gingival health associated with commercially available stannous fluoride-containing dentifrices as compared to a sodium fluoride control dentifrice
    • Authors: Geisinger, M.L., Geurs, N.C., Novy, B., Takesh, T., Wilder-Smith, P.
    • Year: 2023
    • Citations: 2
  7. Authors’ Response
    • Authors: Harrel, S.K., Rethman, M.P., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2023
  8. When is periodontal maintenance not enough?: The need for clinical guidance
    • Authors: Harrel, S.K., Rethman, M.P., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2023
  9. Effect of EDTA Gel on Residual Subgingival Calculus and Biofilm: An In Vitro Pilot Study
    • Authors: Cobb, C.M., Harrel, S.K., Zhao, D., Spencer, P.
    • Year: 2023
    • Citations: 4
  10. Commentary Letters
    • Authors: Rethman, M.P., Harrel, S.K., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2022

 

 

Rumi Ueha | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Prof. Rumi Ueha | Medicine and Dentistry | Best Researcher Award

Director at Swallowing Center/The University of Tokyo Hospital, Japan

Dr. Rumi Ueha is a distinguished specialist in otolaryngology, focusing on airway surgery, swallowing disorders, and olfactory disorders. Holding both an M.D. and Ph.D., Dr. Ueha has accumulated significant expertise through her academic and clinical career. She has contributed extensively to the medical field, particularly in research concerning dysphagia, pediatric airway, chronic airway inflammation, and the regeneration of olfactory receptor cells. Dr. Ueha’s leadership is evident through her current position as Director and Associate Professor at the University of Tokyo, where she combines research, clinical practice, and mentorship. She is internationally recognized for her research in swallowing surgery and airway management, frequently collaborating with institutions across Japan and globally.

Professional Profile

Education:

Dr. Ueha earned her M.D. from the University of Tokyo in 2003, followed by her Ph.D. in 2017, also from the University of Tokyo. Her educational journey includes extensive training in otolaryngology and head and neck surgery, with specialized fellowships in broncho-esophagology. She has studied at renowned institutions, such as the University of California, Davis, and the University of Michigan, further solidifying her academic foundation. This rigorous education laid the groundwork for her research into complex disorders involving the airway, swallowing, and olfaction.

Professional Experience:

Dr. Ueha’s professional journey spans various prestigious roles, beginning as a resident and fellow in otolaryngology at the University of Tokyo and NTT Medical Center. Over the years, she advanced through key positions such as Assistant Professor and Project Lecturer, before being appointed as Director and Associate Professor. Her clinical and research work at the Swallowing Center of the University of Tokyo Hospital has contributed to groundbreaking advancements in dysphagia and swallowing surgery. She has also held visiting researcher roles, expanding her global network and research opportunities.

Research Interests:

Dr. Ueha’s research primarily focuses on the medical and surgical management of swallowing disorders (dysphagia), airway surgery, and olfactory disorders. She is particularly interested in swallowing surgery, chronic airway inflammation, and esophageal dysmotility. Dr. Ueha has explored innovative approaches in airway virtual reality, voice surgery, and pediatric airway management. Additionally, her work in olfactory receptor cell regeneration and the effects of aging on the olfactory system highlights her commitment to advancing treatment options for patients with sensory impairments. Her research also investigates the impact of SARS-CoV-2 on these systems.

Research Skills:

Dr. Ueha’s research skills are broad and multidisciplinary, combining clinical expertise with innovative technologies. She has demonstrated advanced knowledge in airway surgery, swallowing rehabilitation, and neurophysiology. Her skills also extend to virtual reality applications for airway management, showing her adaptability to emerging technologies. Dr. Ueha excels in clinical trials, with a focus on neuromuscular diseases and their impact on swallowing. Her ability to conduct translational research that bridges laboratory findings with clinical applications has led to advancements in treating complex airway and swallowing conditions.

Awards and Honors:

Dr. Ueha has received numerous prestigious awards in recognition of her contributions to otolaryngology and research. These include the Woman Award 2024 by the Oto-Rhino-Laryngological Society of Japan and the Excellence Award at the 16th Scientific Meeting of the Japanese Society of Anti-Aging Medicine. She has also been honored with several first-place prizes, including those for her management improvement projects at the University of Tokyo Hospital. Her recognition in the academic community extends to multiple journal editorial board positions, including for Auris Nasus Larynx and the Japanese Journal of Rhinology, where she influences advancements in her field.

Conclusion:

Dr. Rumi Ueha is a highly accomplished researcher and academic leader in the field of otolaryngology, particularly in swallowing disorders and airway surgery. Her strong academic background, multiple accolades, and extensive international experience make her an outstanding candidate for the Best Researcher Award. While further efforts in research funding and interdisciplinary collaborations would elevate her work, her substantial contributions to her field position her as a leader in otolaryngology and swallowing research.

Publication Top Notes

  • English as a Foreign Language Instructors’ Questioning Behaviors and Strategy Uses for Reflective Learning Facilitation
    • Authors: Not specified
    • Year: Not specified
  • A Narrative Review of Basic and Clinical Studies for Vocal Fold Regeneration Therapies
    • Authors: Cathrine Miura, Rumi Ueha, Maria Angela Dealino, Naoyuki Matsumoto, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1016/j.anl.2024.10.011
  • A Retrospective Study of Cricotracheostomy: Indications, Techniques, and Clinical Outcomes
    • Authors: Kana Nanjo, Rumi Ueha, Maria A. Dealino, Naoyuki Matsumoto, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1002/ohn.1053
  • Swallowing Virtual Reality as a Novel Diagnostic Tool for Severe Dysphagia After Deep Neck Infection: A Case Report
    • Authors: Takahiro Katsuno, Rumi Ueha, Kana Nanjyo, Kazuaki Matsuda, Cathrine Miura, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.21203/rs.3.rs-4725568/v1
  • Esophageal Dysmotility in Multiple System Atrophy: A Retrospective Cross-Sectional Study
    • Authors: Rumi Ueha, Misaki Koyama, Akiko Seto, Taku Sato, Takao Goto, Kenta Orimo, Jun Mitsui, Tatsuya Yamasoba
    • Year: 2024
    • DOI: 10.3390/jcm13175026
  • Severe Dysphagia in a Patient with Wallenberg Syndrome and Killian Jamieson Diverticulum: A Case Report
    • Authors: Carmel Cotaoco, Takao Goto, Misaki Koyama, Taku Sato, Kenji Kondo, Rumi Ueha
    • Year: 2024
    • DOI: 10.1007/s42399-024-01713-2
  • Swallowing Improvement Surgeries
    • Authors: Carmel Cotaoco, Rumi Ueha, Misaki Koyama, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1007/s00405-024-08452-z
  • Severe Dysphagia in a Patient with Wallenberg Syndrome and Killian Jamieson Diverticulum: A Case Report (Preprint)
  • Use of CT for Dysphagia Evaluation: Advantages and Disadvantages in the Study of Swallowing
  • Three-Dimensional Computed Tomography Features of Recurrent Laryngeal Nerve Paralysis Due to Aortic Aneurysm
    • Authors: Jumpei Sasakawa, Takao Goto, Taku Sato, Misaki Koyama, Rumi Ueha, Tatsuya Yamasoba
    • Year: 2024
    • DOI: 10.1007/s42399-024-01685-3

 

 

Laura Bauman | Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Laura Bauman | Dentistry |Best Researcher Award

Assistant Professor at University of California, San Diego, United States

Dr. Laura Elizabeth Bauman, a pediatric gastroenterologist, excels in both clinical and academic settings, making her a strong candidate for the Best Researcher Award. She completed her fellowship at Cincinnati Children’s Medical Center and has been recognized with several prestigious awards, including the Arnold W. Strauss Award and the Young Investigator Travel Award. Dr. Bauman’s leadership roles include co-directing the Fecal Microbial Transplant Program and spearheading quality improvement initiatives at Rady Children’s Pediatric IBD Center. As a peer reviewer for top journals and an active member of professional organizations, she contributes significantly to the advancement of pediatric gastroenterology. Her dedication to service is evident in her work with the Crohn’s and Colitis Foundation and her leadership in fostering inclusivity at Rady Children’s Hospital. While further expanding her grant funding and publication portfolio would strengthen her profile, Dr. Bauman’s commitment to research and patient care makes her an outstanding researcher.

Profile:

Education:

Dr. Laura Elizabeth Bauman has a robust academic background, beginning with her Bachelor of Arts in Human Biology from Stanford University in 2007. She went on to earn her Medical Doctorate from the Geisel School of Medicine at Dartmouth in 2012, where she conducted research under Dr. Kari Rosenkranz. Following medical school, Dr. Bauman completed her pediatric internship and residency at the University of Utah from 2012 to 2015, with mentorship from Drs. Mark Deneau and M. Kyle Jensen. She then pursued specialized training through a Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship at Cincinnati Children’s Medical Center from 2015 to 2018, working with Dr. Lee A. Denson. This extensive education, paired with her research and clinical training in leading institutions, has equipped Dr. Bauman with the expertise needed to excel in pediatric gastroenterology, with a focus on inflammatory bowel diseases and clinical research.

Professional Experience:

Dr. Laura Elizabeth Bauman’s professional experience is marked by her dedication to pediatric gastroenterology and her leadership in both clinical and academic settings. Since completing her fellowship at Cincinnati Children’s Medical Center in 2018, she has played pivotal roles at Rady Children’s Hospital in San Diego, where she co-directs the Fecal Microbial Transplant Program and leads quality improvement initiatives for pediatric inflammatory bowel disease (IBD) patients. Dr. Bauman is a key member of the hospital’s Gastroenterology Fellowship Clinical Competency Committee and collaborates on interdisciplinary projects to enhance patient care. She also serves on national committees, such as the Crohn’s and Colitis Foundation’s Pediatric Affairs Committee, contributing to the development of educational resources and clinical guidelines. A peer reviewer for top gastroenterology journals, Dr. Bauman remains actively involved in research, mentorship, and patient care, solidifying her reputation as a leader in pediatric gastroenterology.

Research Skills:

Dr. Laura Elizabeth Bauman possesses advanced research skills honed through years of focused academic and clinical inquiry in pediatric gastroenterology. Her expertise lies in inflammatory bowel diseases (IBD), where she has led and contributed to numerous research projects aimed at improving clinical outcomes for pediatric patients. Dr. Bauman’s ability to design, implement, and oversee research is demonstrated by her leadership in quality improvement initiatives, such as developing standardized care protocols for acute severe colitis at Rady Children’s Hospital. She is skilled in interdisciplinary collaboration, as shown by her work on the Fecal Microbial Transplant Program and her involvement in the creation of the Inpatient Acute Severe Ulcerative Colitis order set. Additionally, Dr. Bauman is an experienced peer reviewer for leading journals and has been recognized with awards, including the Arnold W. Strauss Award. Her capacity to blend clinical practice with research makes her an asset to the field of pediatric gastroenterology.

Award and Recognition:
Dr. Laura Elizabeth Bauman has received numerous awards and recognitions that highlight her excellence in research, clinical practice, and education. Notably, she was awarded the prestigious Arnold W. Strauss Award, a competitive $10,000 grant aimed at advancing clinical fellows’ research, specifically for her work on refractory ulcerative colitis. She also earned the Young Investigator Travel Award from the Crohn’s and Colitis Congress, recognizing her contributions to cutting-edge research in pediatric gastroenterology. In 2013, she was honored with the Golden Apple Award from the University of Utah’s Department of Pediatrics for her exceptional teaching and mentorship of medical students. Additionally, Dr. Bauman was selected as a candidate for the National Center for Leadership in Academic Medicine in 2023, a professional development program for junior faculty at UC San Diego. These accolades reflect Dr. Bauman’s commitment to advancing her field and her outstanding capabilities as both a researcher and educator.

Conclusion:

Dr. Laura Elizabeth Bauman is an outstanding candidate for the Research for Best Researcher Award, with a deep commitment to advancing pediatric gastroenterology through research, leadership, and service. While areas such as increasing her publication profile and securing larger grants could further strengthen her candidacy, her current achievements in clinical research and professional development make her a highly competitive nominee for this award.

Publication Top Notes:

  1. Mould DR, Upton RN, Wojciechowski J.
    Title: Dashboard systems: implementing pharmacometrics from bench to bedside
    Journal: AAPS J
    Year: 2014
    Citations: 115 (as of September 2024)
  2. Eser A, Primas C, Reinisch S, et al.
    Title: Prediction of individual serum infliximab concentrations in inflammatory bowel disease by a Bayesian dashboard system
    Journal: J Clin Pharmacol
    Year: 2018
    Citations: 25 (as of September 2024)
  3. Hyams J, Walters TD, Crandall W, et al.
    Title: Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension
    Journal: Curr Med Res Opin
    Year: 2011
    Citations: 229 (as of September 2024)
  4. Crombé V, Salleron J, Savoye G, et al.
    Title: Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study
    Journal: Inflamm Bowel Dis
    Year: 2011
    Citations: 310 (as of September 2024)
  5. Wine E, Mack DR, Hyams J, et al.
    Title: Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
    Journal: J Crohns Colitis
    Year: 2013
    Citations: 152 (as of September 2024)
  6. Hyams J, Crandall W, Kugathasan S, et al.; REACH Study Group
    Title: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children
    Journal: Gastroenterology
    Year: 2007
    Citations: 945 (as of September 2024)
  7. Merras-Salmio L, Kolho KL.
    Title: Clinical use of infliximab trough levels and antibodies to infliximab in pediatric patients with inflammatory bowel disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 62 (as of September 2024)
  8. Moore C, Corbett G, Moss AC.
    Title: Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease
    Journal: J Crohns Colitis
    Year: 2016
    Citations: 310 (as of September 2024)
  9. Frymoyer A, Hoekman DR, Piester TL, et al.
    Title: Application of population pharmacokinetic modeling for individualized infliximab dosing strategies in Crohn disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 63 (as of September 2024)
  10. Vande Casteele N, Khanna R, Levesque BG, et al.
    Title: The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease
    Journal: Gut
    Year: 2015
    Citations: 725 (as of September 2024)

 

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79

 

 

Royston Liew | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Mr. Royston Liew | Medicine and Dentistry | Best Researcher Award

Student at Duke-NUS Medical School, Singapore

Dr. Liew Yew Meng Royston is an emerging researcher with a background in Chemical and Biomolecular Engineering, focusing on the molecular mechanisms underlying Hepatocellular Carcinoma (HCC), particularly in None-B-None-C HCC patients. His research integrates engineering principles with biological sciences, offering a novel approach to understanding complex disease pathways, such as bile acid homeostasis. Dr. Royston is proactive in his research endeavors, having initiated wet-lab experiments months in advance under the guidance of Professor Pierce Chow. His work has led to significant findings in the role of post-translational modifications in liver-gut homeostasis. In addition to his research, Dr. Royston has been recognized for his innovation with multiple patents and awards, including the National Runner-Up in the James Dyson Award for his work in vertical farming. His interdisciplinary approach and commitment to advancing medical research make him a promising figure in the field of oncology and biomedical engineering.

Profile

Education

Dr. Liew Yew Meng Royston holds a Bachelor of Engineering (Honours) in Chemical and Biomolecular Engineering from Nanyang Technological University, Singapore, where he studied from 2018 to 2022. His academic training provided a strong foundation in engineering principles, which he has effectively applied to his research in the biomedical field. During his undergraduate studies, Dr. Royston demonstrated a keen interest in integrating engineering with biological systems, laying the groundwork for his current research in Hepatocellular Carcinoma (HCC). His educational journey was marked by academic excellence, earning him a place on the Dean’s List for the 2018/2019 academic year. The interdisciplinary nature of his education has equipped Dr. Royston with the skills to approach complex biological problems with precision and innovation, making significant contributions to his field. His commitment to academic and research excellence continues to drive his pursuit of advanced knowledge in medicine and biomedical engineering.

Professional Experience

Dr. Liew Yew Meng Royston has demonstrated considerable professional experience in both research and innovation. He is currently focused on Hepatocellular Carcinoma (HCC) research, specifically None-B-None-C HCC (NBNC HCC), where he applies his background in chemical and biomolecular engineering to investigate bile acid homeostasis and its implications for liver function. Before beginning his Duke-NUS Phase 3 Scholarly Research Project, Dr. Royston proactively engaged in preliminary research with Professor Pierce Chow, resulting in significant novel findings. His research approach integrates engineering principles with biological systems, employing techniques such as molecular pathway modeling and process optimization. Beyond his research, Dr. Royston has made notable contributions to the field of vertical farming, with a patent for a modular hydroponic system and recognition through awards like the James Dyson Award and the APAC CEO of the Year Awards. His expertise reflects a blend of scientific rigor and innovative problem-solving.

Research Interest

Dr. Liew Yew Meng Royston’s research interest centers on elucidating the molecular and cellular mechanisms underlying Hepatocellular Carcinoma (HCC), specifically focusing on None-B-None-C Hepatocellular Carcinoma (NBNC HCC). His work involves investigating the dysregulation of bile acid homeostasis pathways and their impact on liver function in NBNC HCC patients. By applying principles from Chemical and Biomolecular Engineering, Dr. Royston integrates metabolomic, microbiomic, and transcriptomic data to identify critical alterations in disease mechanisms. His research explores the role of post-translational modifications, particularly acetylation of the FXR protein, in influencing bile acid production and liver-gut homeostasis. Additionally, he investigates the effects of highly processed diets on the microbiome and their subsequent role in HCC development. Dr. Royston’s interdisciplinary approach aims to deepen understanding of HCC and develop innovative strategies for its treatment, blending engineering precision with advanced biological research.

Research Skills

Dr. Liew Yew Meng Royston possesses a diverse skill set tailored to his research in Hepatocellular Carcinoma (HCC). His skills include advanced techniques in metabolomics, microbiomics, and transcriptomics, which are essential for analyzing complex biological data. Dr. Royston is proficient in molecular pathway modeling and process optimization, applying engineering principles to biological systems. His expertise extends to wet-lab experimentation, including the study of post-translational modifications of proteins and their effects on gene transcription. Additionally, Dr. Royston employs systems-level approaches to integrate various biological and biochemical data, enhancing the precision and depth of his research. His proactive approach to research, demonstrated by initiating preliminary work and securing foundational results, further highlights his commitment and technical capabilities in addressing complex biomedical challenges.

Award and Recognition

Dr. Liew Yew Meng Royston has received significant recognition for his contributions to research and innovation. Notably, he was awarded the National Runner-Up position in the James Dyson Award in 2022 for his work on vertical farming, highlighting his innovative approach to urban agriculture. His invention of a modular hydroponic farming apparatus was patented internationally, underscoring his inventive capabilities. In addition to these achievements, Dr. Royston received the APAC CEO of the Year Awards for Most Innovative Agribusiness CEO in 2022, reflecting his impact on the agribusiness sector. His research efforts have also been supported by several grants, including the SSG Tech POC Grant of $250,000 and the SSG Founder’s Startup Grant of $50,000. Dr. Royston’s academic excellence was recognized through his inclusion on the Dean’s List at Nanyang Technological University for the academic year 2018/2019, further attesting to his dedication and outstanding performance in his field.

Conclusion

Liew Yew Meng Royston demonstrates significant potential as a researcher with a strong interdisciplinary approach and innovative mindset. His proactive research efforts, combined with his engineering background, position him as a promising candidate for the Best Researcher Award. However, enhancing his publication record and securing research grants could further solidify his standing in the research community.

Publication Top Notes

Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis

  • Authors: Ang, A.J.Y., Liew, R.Y.M., Aw, V.Z.J., Chia, C.S., Shannon, N.B.
  • Year: 2024
  • Journal: European Journal of Surgical Oncology
  • Volume: 50
  • Issue: 11
  • Article Number: 108623

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11